<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): March 16, 2000
OXBORO MEDICAL, INC.
-----------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Minnesota 000-18785 41-1391803
- ----------------------------- ------------------------ -------------------
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
13828 Lincoln Street NE
Ham Lake, Minnesota 55304
- ------------------------------ ----------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (763) 755-9516
<PAGE>
Items 1, 2, 3, 5, 6 and 8 are not applicable and therefore omitted.
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
(a) Previous Independent Accountants
On March 16, 2000, Oxboro Medical, Inc. ("Oxboro"), formerly Oxboro
Medical International, Inc., dismissed Grant Thornton LLP as its independent
accountants. The decision to change accountants was recommended by the Oxboro
Board of Directors.
In connection with the audits of the fiscal years ended September 30,
1999 and 1998, and in the subsequent interim period through the date of
dismissal, there were no disagreements with Grant Thornton LLP on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedures, which disagreements, if not resolved to the satisfaction of
Grant Thornton LLP, would have caused them to make reference thereto in their
report on the financial statements for such years.
Grant Thornton LLP's report on the consolidated financial statements
as of and for the years ended September 30, 1999 and 1998, did not contain
any adverse opinion or disclaimer of opinion, nor was it qualified as to
uncertainty, audit scope, or accounting principles.
Oxboro has requested that Grant Thornton LLP furnish it with a letter
addressed to the SEC stating whether or not it agrees with the above statements.
A copy of such letter, dated March 22, 2000, is filed as Exhibit 1 to this Form
8-K.
(b) New Independent Accountants
On March 16, 2000, Oxboro engaged Lund Koehler Cox & Arkema LLP as its
new independent accountants.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
Exhibit 1. Grant Thornton LLP Letter re Change In Certifying
Accountant.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
OXBORO MEDICAL, INC.
By /s/Matthew E. Bellin
------------------------------------------------
Its President
-----------------------------------------------
Dated: March 23, 2000
3
<PAGE>
EXHIBIT 1
March 22, 2000
Securities and Exchange Commission
Mail Stop 9-5
450 5th Street, N.W.
Washington, D.C. 20549
Re: Oxboro Medical, Inc.
File No. 0-18785
Ladies and Gentlemen:
We have read Item 4(a) of the Form 8-K of Oxboro Medical, Inc. dated March
16, 2000, and agree with the statements contained therein.
Yours truly,
/s/ GRANT THORNTON LLP
E-1
